Pulmatrix, Inc.
US ˙ NasdaqCM ˙ US74584P3010

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Matthew L Sherman. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Matthew L Sherman har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
EVP & Chief Medical Officer 0
US:PIRS / Pieris Pharmaceuticals, Inc. Director 40 000
Director 13 889
US:PULM / Pulmatrix, Inc. Director 15 000
US:XLRN / Acceleron Pharma Inc EVP & Chief Medical Officer 68 767
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Matthew L Sherman. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp PULM / Pulmatrix, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i PULM / Pulmatrix, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
2018-04-03 PULM Sherman Matthew L 20 000 1 333 69 120

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

PULM / Pulmatrix, Inc. Insider Trades
Internhandel PULM / Pulmatrix, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i PULM / Pulmatrix, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

PULM / Pulmatrix, Inc. Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Matthew L Sherman som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
U - Other −72 261 0 −100,00
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer −72 029 72 261 −49,92
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 34 157 144 290 31,01
2024-02-20 2024-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −2 615 108 739 −2,35 15,62 −40 840 1 698 253
2024-02-20 2024-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 17 275 111 354 18,36
2024-01-18 2024-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −2 435 94 079 −2,52 14,47 −35 234 1 361 295
2023-12-14 2023-12-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −2 792 96 514 −2,81 15,37 −42 905 1 483 140
2023-12-14 2023-12-12 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 8 244 99 306 9,05
2023-10-31 2023-10-30 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −2 360 90 628 −2,54 12,02 −28 362 1 089 131
2023-10-31 2023-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 8 244 92 988 9,73
2023-10-04 2023-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −2 942 84 744 −3,36 12,68 −37 305 1 074 554
2023-06-21 2023-06-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −1 655 87 686 −1,85 14,40 −23 835 1 262 836
2023-02-17 2023-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −971 88 145 −1,09 15,10 −14 661 1 330 901
2023-02-17 2023-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 16 488 89 116 22,70
2023-01-19 2023-01-17 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −2 403 72 628 −3,20 21,24 −51 043 1 542 713
2022-10-05 2022-10-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −2 587 74 297 −3,36 18,73 −48 455 1 391 583
2022-06-21 2022-06-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −1 768 76 884 −2,25 10,75 −19 006 826 503
2022-02-18 2022-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −984 76 790 −1,27 9,05 −8 905 694 950
2022-01-20 2022-01-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 82 000 82 000
2022-01-20 2022-01-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 20 500 77 774 35,79
2021-12-17 2021-12-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 82 265 82 265
2021-12-17 2021-12-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 11 100 57 274 24,04
2021-10-06 2021-10-04 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −2 659 46 029 −5,46 33,17 −88 199 1 526 782
2021-06-29 2021-06-25 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40 000 40 000
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 49 900 49 900
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 11 100 48 386 29,77
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale −132 37 286 −0,35 48,87 −6 451 1 822 167
2020-12-11 2020-12-09 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to buy)
M - Exercise −207 147 096 −0,14
2020-12-11 2020-12-09 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 207 37 418 0,56 34,43 7 127 1 288 302
2020-11-18 2020-11-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to buy)
M - Exercise −2 697 147 303 −1,80
2020-11-18 2020-11-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 2 697 37 211 7,81 34,43 92 858 1 281 175
2020-10-06 2020-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
F - Taxes −2 632 34 128 −7,16 51,15 −134 618 1 745 535
2020-06-25 2020-06-23 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40 000 40 000
2020-02-20 2020-02-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award −10 520 10 520 −50,00
2020-02-20 2020-02-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 1 760 36 760 5,03
2020-01-28 2020-01-25 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20 000 20 000
2019-10-17 2019-10-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 150 000 150 000
2019-10-17 2019-10-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 35 000 35 000
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 13 889 13 889
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
D - Sale to Issuer −27 777 0 −100,00
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 18 506 18 506
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 13 218 13 218
2019-08-02 2019-07-31 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
D - Sale to Issuer −63 447 0 −100,00
2019-05-20 2019-05-16 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 15 000 15 000
2019-05-14 2019-05-10 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 25 000 25 000
2019-01-29 2019-01-25 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20 000 20 000
2018-10-25 2018-10-24 4 PIRS PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30 000 30 000
2018-06-06 2018-06-05 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 124 000 124 000
2018-05-25 2018-05-23 4 (NLNK) NEWLINK GENETICS CORP
Stock Option (Right to Buy)
A - Award 27 777 27 777
2018-04-05 2018-04-03 4 PULM Pulmatrix, Inc.
Series A Warrant (right to buy)
P - Purchase 20 000 20 000
2018-04-05 2018-04-03 4 PULM Pulmatrix, Inc.
Series B Warrant (right to buy)
P - Purchase 20 000 20 000
2018-04-05 2018-04-03 4 PULM Pulmatrix, Inc.
Common Stock
P - Purchase 20 000 20 000
2018-04-04 2018-04-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −900 68 767 −1,29 39,04 −35 136 2 684 664
2018-04-04 2018-04-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 700 69 667 −5,04 38,28 −141 636 2 666 853
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 033 73 367 −2,70 43,33 −88 090 3 178 992
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 300 75 400 −2,96 42,40 −97 520 3 196 960
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −300 77 700 −0,38 40,86 −12 258 3 174 822
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −150 78 000 −0,19 39,91 −5 986 3 112 980
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 600 78 150 −2,01 39,24 −62 784 3 066 606
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −16 650 79 750 −17,27 38,32 −638 028 3 056 020
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −8 000 0 −100,00
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −16 000 96 400 −14,23 32,00 −512 000 3 084 800
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 8 000 112 400 7,66 7,12 56 960 800 288
2017-03-22 2017-03-20 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 4 400 4 400
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 47 300 47 300
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 7 900 104 400 8,19
2017-01-06 2017-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 600 96 500 −1,63 27,62 −44 192 2 665 330
2017-01-06 2017-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 98 100 −0,41 26,81 −10 724 2 630 061
2016-10-03 2016-09-29 4 PULM Pulmatrix, Inc.
Stock Option (Right to Buy)
A - Award 8 800 8 800
2016-08-11 2016-08-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −17 000 8 000 −68,00
2016-08-11 2016-08-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −1 896 0 −100,00
2016-08-11 2016-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 17 000 98 500 20,86 7,12 121 040 701 320
2016-08-11 2016-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 1 896 81 500 2,38 5,28 10 011 430 320
2016-07-07 2016-07-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −6 000 1 896 −75,99
2016-07-07 2016-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 6 000 79 604 8,15 5,28 31 680 420 309
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 604 7 896 −36,83
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −3 500 0 −100,00
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 896 0 −100,00
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −20 207 73 604 −21,54 34,89 −705 022 2 568 044
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −5 793 93 811 −5,82 34,20 −198 121 3 208 336
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 604 99 604 4,85 5,28 24 309 525 909
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3 500 95 000 3,83 3,88 13 580 368 600
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 896 91 500 6,89 5,08 29 952 464 820
2016-04-08 2016-04-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −14 000 5 896 −70,37
2016-04-08 2016-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −23 920 85 604 −21,84 32,00 −765 440 2 739 328
2016-04-08 2016-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 14 000 109 524 14,66 5,08 71 120 556 382
2016-04-08 2016-04-06 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 080 95 524 −2,13 32,00 −66 560 3 056 768
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 36 000 36 000
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 6 000 97 604 6,55
2015-10-16 2015-10-15 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 8 500 −5,56 23,94 −11 970 203 490
2015-10-16 2015-10-15 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −700 9 000 −7,22 22,69 −15 883 204 210
2015-10-16 2015-10-15 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 400 91 604 −2,55 23,93 −57 432 2 192 084
2015-10-16 2015-10-15 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 400 94 004 −2,49 22,66 −54 384 2 130 131
2015-09-18 2015-09-16 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 9 700 −3,96 34,96 −13 984 339 112
2015-09-18 2015-09-16 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 96 404 −0,21 34,93 −6 986 3 367 392
2015-09-18 2015-09-16 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −300 96 604 −0,31 33,55 −10 065 3 241 064
2015-09-18 2015-09-16 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 100 96 904 −1,12 32,22 −35 442 3 122 247
2015-09-11 2015-09-09 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 46 000 98 004 88,45
2015-08-25 2015-08-24 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −20 000 3 500 −85,11
2015-08-25 2015-08-24 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 20 000 52 004 62,49 3,88 77 600 201 776
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 600 19 896 −7,44
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 0 −100,00
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 10 100 −1,94 31,69 −6 338 320 069
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 10 100 −1,94 31,69 −6 338 320 069
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −800 10 300 −7,21 30,99 −24 792 319 197
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 11 100 −3,48 31,95 −12 780 354 645
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 400 32 204 −4,17 31,00 −43 400 998 324
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 600 33 604 5,00 5,08 8 128 170 708
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 210 32 004 −3,64 31,60 −38 236 1 011 326
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 790 33 214 −7,75 30,83 −86 016 1 023 988
2015-08-19 2015-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 36 004 12,50 0,48 1 920 17 282
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −800 21 496 −3,59
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 4 000 −50,00
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 11 500 −1,71 33,22 −6 644 382 030
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 11 700 −7,87 32,31 −32 310 378 027
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −800 32 004 −2,44 33,22 −26 576 1 063 173
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 800 32 804 2,50 5,08 4 064 166 644
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 32 004 −0,31 32,74 −3 274 1 047 811
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 900 32 104 −10,83 32,29 −125 931 1 036 638
2015-07-21 2015-07-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 36 004 12,50 0,48 1 920 17 282
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 600 22 296 −6,70
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 8 000 −33,33
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 12 700 −3,05 31,07 −12 428 394 589
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 13 100 −7,09 31,57 −31 570 413 567
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −5 600 32 004 −14,89 31,57 −176 792 1 010 366
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 600 37 604 4,44 5,08 8 128 191 028
2015-06-19 2015-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 36 004 12,50 0,48 1 920 17 282
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 600 23 896 −6,28
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 12 000 −25,00
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 400 14 100 −9,03 32,20 −45 080 454 020
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −5 600 32 004 −14,89 32,41 −181 496 1 037 250
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 600 37 604 4,44 5,08 8 128 191 028
2015-05-19 2015-05-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 36 004 12,50 0,48 1 920 17 282
2015-04-21 2015-04-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 16 000 −20,00
2015-04-21 2015-04-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 15 500 −6,06 33,50 −33 500 519 250
2015-04-21 2015-04-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 000 32 004 −11,11 33,53 −134 120 1 073 094
2015-04-21 2015-04-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 36 004 12,50 0,48 1 920 17 282
2015-04-17 2015-04-16 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −12 000 23 500 −33,80
2015-04-17 2015-04-16 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 12 000 32 004 59,99 3,88 46 560 124 176
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −800 25 496 −3,04
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 20 000 −16,67
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 16 500 −1,20 41,21 −8 242 679 965
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 16 700 −0,60 41,60 −4 160 694 720
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −900 16 800 −5,08 41,13 −37 017 690 984
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −800 20 004 −3,85 41,21 −32 968 824 365
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 800 20 804 4,00 5,08 4 064 105 684
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −721 20 004 −3,48 41,63 −30 015 832 767
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 279 20 725 −13,66 41,07 −134 669 851 176
2015-03-20 2015-03-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 24 004 20,00 0,48 1 920 11 522
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 15 000 15 000
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 600 26 296 −5,74
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 24 000 −14,29
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −300 17 700 −1,67 41,38 −12 414 732 426
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −700 18 000 −3,74 40,63 −28 441 731 340
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 18 700 −2,09 40,92 −16 368 765 204
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 600 20 004 −7,41 40,21 −64 336 804 361
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 600 21 604 8,00 5,08 8 128 109 748
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 20 004 −0,99 42,07 −8 414 841 568
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 001 20 204 −4,72 41,40 −41 441 836 446
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 799 21 205 −11,66 40,66 −113 807 862 195
2015-03-06 2015-03-04 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 24 004 20,00 0,48 1 920 11 522
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 28 000 −12,50
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 600 27 896 −5,42
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 19 100 −4,98 41,60 −41 600 794 560
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 20 100 −1,95 41,70 −16 680 838 170
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 486 24 004 −9,38 41,81 −103 940 1 003 607
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 514 22 490 −6,31 41,23 −62 422 927 263
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 24 004 20,00 0,48 1 920 11 522
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 600 20 004 −7,41 41,78 −66 848 835 767
2015-01-22 2015-01-20 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 600 21 604 8,00 5,08 8 128 109 748
2015-01-09 2015-01-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 41 000 41 000
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 32 000 −11,11
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 20 500 −4,65 40,19 −40 190 823 895
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 20 004 −0,99 40,60 −8 120 812 162
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 800 20 204 −15,83 40,13 −152 494 810 787
2014-12-19 2014-12-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 24 004 20,00 0,48 1 920 11 522
2014-12-19 2014-12-17 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −2 000 35 500 −5,33
2014-12-19 2014-12-17 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 2 000 20 004 11,11 3,88 7 760 77 616
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 29 496 −11,94
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 21 500 −2,27 43,73 −21 865 940 195
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 22 000 −2,22 43,16 −21 580 949 520
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 065 18 004 −5,58 43,88 −46 732 790 016
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 935 19 069 −13,34 43,32 −127 144 826 069
2014-12-12 2014-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 22 004 22,22 5,08 20 320 111 780
2014-12-12 2014-05-19 4/A XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 13 922 −0,71 32,23 −3 223 448 706
2014-12-12 2014-05-19 4/A XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 900 14 022 −11,93 31,47 −59 793 441 272
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 082 36 000 −10,18
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −300 22 500 −1,32 34,51 −10 353 776 475
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −700 22 800 −2,98 33,42 −23 394 761 976
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −907 19 940 −4,35 34,54 −31 328 688 728
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 175 20 847 −13,22 33,54 −106 490 699 208
2014-11-18 2014-11-18 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 082 24 022 20,47 0,48 1 959 11 531
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 504 33 496 −4,30
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −2 414 0 −100,00
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 23 500 −1,67 33,70 −13 480 791 950
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −600 23 900 −2,45 32,64 −19 584 780 096
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 317 19 940 −10,41 33,59 −77 828 669 785
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 601 22 257 −6,71 32,43 −51 920 721 795
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 504 23 858 6,73 5,08 7 640 121 199
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 2 414 22 354 12,11 1,80 4 345 40 237
2014-10-20 2014-10-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 24 500 −3,92 29,12 −29 120 713 440
2014-10-20 2014-10-20 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 918 19 940 −16,42 29,10 −114 014 580 254
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 082 2 414 −62,84
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 25 500 −0,78 30,41 −6 082 775 455
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −800 25 700 −3,02 29,27 −23 416 752 239
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 193 23 858 −4,76 30,28 −36 124 722 420
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 889 25 051 −10,34 29,17 −84 272 730 738
2014-10-09 2014-10-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 082 27 940 17,11 1,80 7 348 50 292
2014-09-19 2014-09-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 26 500 −3,64 25,50 −25 500 675 750
2014-09-19 2014-09-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 000 23 858 −14,36 25,47 −101 880 607 663
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 6 496 −38,11
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 27 500 −3,51 25,79 −25 790 709 225
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 27 858 −0,71 26,40 −5 280 735 451
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 800 28 058 −11,93 25,80 −98 040 723 896
2014-09-04 2014-09-03 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 31 858 14,36 1,80 7 200 57 344
2014-08-19 2014-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 28 500 −1,72 30,00 −15 000 855 000
2014-08-19 2014-08-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 000 27 858 −6,70 29,53 −59 060 822 647
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 316 10 496 −29,14
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 684 40 081 −4,03
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 500 29 000 −4,92 29,82 −44 730 864 780
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 29 858 −0,33 30,25 −3 025 903 204
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −5 900 29 958 −16,45 29,77 −175 643 891 850
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 316 35 858 13,68 1,80 7 769 64 544
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 684 31 542 5,64 0,48 808 15 140
2014-08-13 2014-08-12 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −8 000 14 812 −35,07
2014-08-13 2014-08-12 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 8 000 29 858 36,60 1,80 14 400 53 744
2014-07-25 2014-07-23 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −10 000 22 812 −30,48
2014-07-25 2014-07-23 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 10 000 21 858 84,33 1,80 18 000 39 344
2014-07-22 2014-07-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 30 500 −1,61 25,50 −12 750 777 750
2014-07-22 2014-07-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −33 11 858 −0,28 26,78 −884 317 557
2014-07-22 2014-07-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 967 11 891 −14,19 26,39 −51 909 313 803
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −6 000 41 765 −12,56
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −499 31 000 −1,58 29,46 −14 701 913 260
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 001 31 499 −3,08 28,77 −28 799 906 226
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 094 13 858 −18,25 29,39 −90 933 407 287
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 906 16 952 −14,63 28,55 −82 966 483 980
2014-07-11 2014-07-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 6 000 19 858 43,30 0,48 2 880 9 532
2014-06-20 2014-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 32 500 −1,52 34,13 −17 065 1 109 225
2014-06-20 2014-06-18 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 000 13 858 −12,61 34,49 −68 980 477 962
2014-06-13 2014-06-11 4 XLRN ACCELERON PHARMA INC
Option to purchase Common Stock
M - Exercise X −6 000 47 765 −11,16
2014-06-13 2014-06-11 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 500 33 000 −4,35 33,25 −49 875 1 097 250
2014-06-13 2014-06-11 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −6 000 15 858 −27,45 33,23 −199 380 526 961
2014-06-13 2014-06-11 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 6 000 21 858 37,84 0,48 2 880 10 492
2014-05-30 2014-05-28 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −6 000 53 765 −10,04
2014-05-30 2014-05-28 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −6 000 15 858 −27,45 30,97 −185 820 491 122
2014-05-30 2014-05-28 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 6 000 21 858 37,84 0,48 2 880 10 492
2014-05-30 2014-05-28 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 500 34 500 −4,17 30,99 −46 485 1 069 155
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 36 000 −1,37 31,68 −15 840 1 140 480
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 15 858 −0,63 32,23 −3 223 511 103
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 900 15 958 −10,64 31,47 −59 793 502 198
2014-04-24 2014-04-22 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 36 500 −2,67 35,75 −35 750 1 304 875
2014-04-24 2014-04-22 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 936 15 922 −10,84 36,08 −69 851 574 466
2014-04-24 2014-04-22 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 064 17 858 −10,36 35,64 −73 561 636 459
2013-12-09 2013-12-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 29 000 29 000
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
19 922
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
37 500
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)